glp-1 drug news today 2025 ISPOR 2025: Exploring reasons for discontinuation GLP-1 Agonists Weight Loss Drugs

Other manifestations include failure to thrive, low muscle mass, hypotonia, and movement disorders (primarily extrapyramidal) [34]

We monitor comprehensive bloodwork at regular intervals, assess metabolic markers, and adjust dosing to ensure you are progressing toward optimal outcomes safely and effectively

Toxicol Environ Chem

Adopting standards such as Fast Healthcare Interoperability Resources (FHIR) and Clinical Data Interchange Standards Consortium (CDISC), along with automated validation tools, can facilitate data harmonization and interoperability across platforms

(By the way: You can book an appointment with a Midi Health clinician to learn more about glycine supplements and the best care solutions for you.) With night sweats and insomnia, sleep can feel like the Holy Grail during midlife